Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
JAMA Neurol ; 71(4): 484-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24493558

ABSTRACT

IMPORTANCE: To describe the first case of preimplantation genetic diagnosis (PGD) and in vitro fertilization (IVF) performed for the prevention of genetic prion disease in the children of a 27-year-old asymptomatic woman with a family history of Gerstmann-Sträussler-Sheinker syndrome (GSS). OBSERVATIONS: PGD and fertilization cycles resulted in detection of 6 F198S mutation-free embryos. Of these, 2 were selected for embryo transfer to the patient's uterus, yielding a clinical twin pregnancy and birth of healthy but slightly premature offspring with normal development at age 27 months. CONCLUSION AND RELEVANCE: IVF with PGD is a viable option for couples who wish to avoid passing the disease to their offspring. Neurologists should be aware of PGD to be able to better consult at-risk families on their reproductive choices.


Subject(s)
Genetic Testing/methods , Mutation/genetics , Preimplantation Diagnosis/methods , Prion Diseases/diagnosis , Prion Diseases/genetics , Prions/genetics , Adult , Diseases in Twins/diagnosis , Diseases in Twins/genetics , Diseases in Twins/prevention & control , Female , Follow-Up Studies , Humans , Infant, Newborn , Pregnancy , Prion Diseases/prevention & control , Prion Proteins , Risk
2.
Acta Neuropathol Commun ; 1: 80, 2013 Dec 12.
Article in English | MEDLINE | ID: mdl-24330864

ABSTRACT

A novel point mutation resulting in a glutamate-to-glycine substitution in PRNP at codon 200, E200G with codon 129 MV polymorphism (cis valine) and type 2 PrPSc was identified in a patient with a prolonged disease course leading to pathology-proven Jakob-Creutzfeldt disease. Despite the same codon as the most common genetic form of human PRNP mutation, E200K, this novel mutation (E200G) presented with a different clinical and pathological phenotype, including prolonged duration, large vacuoles, no vacuolation in the hippocampus, severe neuronal loss in the thalamus, mild cerebellar involvement, and abundant punctate linear and curvilinear deposition of PrPSc in synaptic boutons and axonal terminals along the dendrites.


Subject(s)
Creutzfeldt-Jakob Syndrome/genetics , Creutzfeldt-Jakob Syndrome/pathology , Point Mutation , Prions/genetics , Brain/pathology , Creutzfeldt-Jakob Syndrome/physiopathology , Creutzfeldt-Jakob Syndrome/psychology , Fatal Outcome , Female , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Middle Aged , Neuropsychological Tests , Pedigree
4.
Ann Neurol ; 70(2): 327-40, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21823158

ABSTRACT

OBJECTIVE: To characterize cognitive and behavioral features, physical findings, and brain atrophy patterns in pathology-proven corticobasal degeneration (CBD) and corticobasal syndrome (CBS) with known histopathology. METHODS: We reviewed clinical and magnetic resonance imaging data in all patients evaluated at our center with either an autopsy diagnosis of CBD (n = 18) or clinical CBS at first presentation with known histopathology (n = 40). Atrophy patterns were compared using voxel-based morphometry. RESULTS: CBD was associated with 4 clinical syndromes: progressive nonfluent aphasia (n = 5), behavioral variant frontotemporal dementia (n = 5), executive-motor (n = 7), and posterior cortical atrophy (n = 1). Behavioral or cognitive problems were the initial symptoms in 15 of 18 patients; less than half exhibited early motor findings. Compared to controls, CBD patients showed atrophy in dorsal prefrontal and perirolandic cortex, striatum, and brainstem (p < 0.001 uncorrected). The most common pathologic substrates for clinical CBS were CBD (35%), Alzheimer disease (AD, 23%), progressive supranuclear palsy (13%), and frontotemporal lobar degeneration (FTLD) with TDP inclusions (13%). CBS was associated with perirolandic atrophy irrespective of underlying pathology. In CBS due to FTLD (tau or TDP), atrophy extended into prefrontal cortex, striatum, and brainstem, whereas in CBS due to AD, atrophy extended into temporoparietal cortex and precuneus (p < 0.001 uncorrected). INTERPRETATION: Frontal lobe involvement is characteristic of CBD, and in many patients frontal, not parietal or basal ganglia, symptoms dominate early stage disease. CBS is driven by medial perirolandic dysfunction, but this anatomy is not specific to a single underlying histopathology. Antemortem prediction of CBD will remain challenging until clinical features of CBD are redefined, and sensitive, specific biomarkers are identified.


Subject(s)
Basal Ganglia/pathology , Basal Ganglia/physiopathology , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/physiopathology , Aged , Aged, 80 and over , Autopsy , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurodegenerative Diseases/diagnosis , Neuropsychological Tests , Syndrome
5.
J Neuropathol Exp Neurol ; 69(12): 1220-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21107135

ABSTRACT

Human prion diseases can be caused by mutations in the prion protein gene PRNP. Prion disease with mutations at codon 188 has been reported in 6 cases, but only 1 had the T188R mutation and it was not pathologically confirmed. We report the clinical, neuropsychologic, imaging, genetic, and neuropathologic features of a patient with familial Creutzfeldt-Jakob disease, associated with a very rare PRNP mutation at T188R. The patient presented with prominent behavioral changes in addition to the more typical cognitive and motorimpairments seen in sporadic Creutzfeldt-Jakob disease. The autopsy confirmed prion disease pathology. This case supports the pathogenicity of the T188 PRNP mutation, demonstrates the variability of clinical phenotypes associated with certain mutations, and emphasizes the importance of testing for genetic prion disease in cases of apparently sporadic atypical dementia.


Subject(s)
Arginine/genetics , Creutzfeldt-Jakob Syndrome/genetics , Mutation, Missense/genetics , Prions/genetics , Threonine/genetics , Creutzfeldt-Jakob Syndrome/complications , Creutzfeldt-Jakob Syndrome/pathology , Dementia/complications , Dementia/genetics , Dementia/pathology , Fatal Outcome , Humans , Male , Middle Aged , Pedigree , Prion Diseases/complications , Prion Diseases/genetics , Prion Diseases/pathology , Prion Proteins
6.
J Geriatr Psychiatry Neurol ; 23(4): 260-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20938042

ABSTRACT

The purpose of this review is to provide a comprehensive update on the genetic causes of frontotemporal lobar degeneration (FTLD). Approximately 40% to 50% of patients diagnosed with FTLD have a family history of a ''related disorder,'' whereas 10% to 40% have an autosomal dominant family history for the disease. At this time, mutations occurring in 2 independent genes located on the same chromosome (MAPT and GRN) have been shown to cause the majority of cases of autosomal dominant FTLD. Specific genetic, molecular, pathological, and phenotypic variations associated with each of these gene mutations are discussed, as well as markers that may help differentiate the 2. In addition, 3 relatively rare, additional genes known to cause familial FTLD are examined in brief. Lastly, genetic counseling issues which may be important to the community clinician are discussed.


Subject(s)
Adenosine Triphosphatases/genetics , Brain/pathology , Cell Cycle Proteins/genetics , DNA-Binding Proteins/genetics , Endosomal Sorting Complexes Required for Transport/genetics , Frontotemporal Lobar Degeneration/genetics , Intercellular Signaling Peptides and Proteins/genetics , Nerve Tissue Proteins/genetics , tau Proteins/genetics , Animals , Family , Frontotemporal Lobar Degeneration/pathology , Frontotemporal Lobar Degeneration/psychology , Genetic Counseling , Genetic Predisposition to Disease , Genetic Variation , Genotype , Humans , Mutation , Phenotype , Progranulins , Tomography, X-Ray Computed , Valosin Containing Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...